Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ward

Showing results (201-210 of 249) with videos related to

Pageof 25
Sort By:
Chemical Communications (Cambridge, England)|May 31, 2006
Biosynthesis of the angiogenesis inhibitor borrelidin: directed biosynthesis of novel analoguesSteven J Moss, Isabelle Carletti, Carlos Olano, et al.
Veterinary Research Communications|May 28, 2024
Targeting canine mammary neoplastic epithelial cells with a reengineered anthrax toxin: first studyIvone Izabel Mackowiak da Fonseca, Márcia Kazumi Nagamine, Luciana Boffoni Gentile, et al.
The Journal of Experimental Medicine|June 25, 2020
Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease modelShoutang Wang, Meer Mustafa, Carla M Yuede, et al.
Plos Biology|July 14, 2023
Correction: TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13AYuka Koike, Sarah Pickles, Virginia Estades Ayuso, et al.
Plos Biology|March 17, 2023
TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13AYuka Koike, Sarah Pickles, Virginia Estades Ayuso, et al.
Journal of Internal Medicine|June 7, 2023
Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease-modifying antirheumatic drugs: A multi-centre cohort studyXinning Tong, Chin-Yao Shen, Ha-Lim Jeon, et al.
Applied and Environmental Microbiology|May 7, 2004
Characterization of humanized antibodies secreted by Aspergillus nigerMichael Ward, Cherry Lin, Doreen C Victoria, et al.
JAMA Neurology|June 13, 2022
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical TrialEdmond Teng, Paul T Manser, Karen Pickthorn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisDaniel M Ramos, Matthew P Nelson, Liz Calzada, et al.
Transfusion|August 10, 2013
A pragmatic approach to embedding patient blood management in a tertiary hospitalMichael F Leahy, Heather Roberts, S Aqif Mukhtar, et al.
Pageof 25

Showing results (201-210 of 249) with videos related to

Sort By:
Pageof 25
Chemical Communications (Cambridge, England)|May 31, 2006
Biosynthesis of the angiogenesis inhibitor borrelidin: directed biosynthesis of novel analoguesSteven J Moss, Isabelle Carletti, Carlos Olano, et al.
Veterinary Research Communications|May 28, 2024
Targeting canine mammary neoplastic epithelial cells with a reengineered anthrax toxin: first studyIvone Izabel Mackowiak da Fonseca, Márcia Kazumi Nagamine, Luciana Boffoni Gentile, et al.
The Journal of Experimental Medicine|June 25, 2020
Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease modelShoutang Wang, Meer Mustafa, Carla M Yuede, et al.
Plos Biology|July 14, 2023
Correction: TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13AYuka Koike, Sarah Pickles, Virginia Estades Ayuso, et al.
Plos Biology|March 17, 2023
TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13AYuka Koike, Sarah Pickles, Virginia Estades Ayuso, et al.
Journal of Internal Medicine|June 7, 2023
Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease-modifying antirheumatic drugs: A multi-centre cohort studyXinning Tong, Chin-Yao Shen, Ha-Lim Jeon, et al.
Applied and Environmental Microbiology|May 7, 2004
Characterization of humanized antibodies secreted by Aspergillus nigerMichael Ward, Cherry Lin, Doreen C Victoria, et al.
JAMA Neurology|June 13, 2022
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical TrialEdmond Teng, Paul T Manser, Karen Pickthorn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisDaniel M Ramos, Matthew P Nelson, Liz Calzada, et al.
Transfusion|August 10, 2013
A pragmatic approach to embedding patient blood management in a tertiary hospitalMichael F Leahy, Heather Roberts, S Aqif Mukhtar, et al.
Pageof 25